midazolam has been researched along with 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3-carboxamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, D; Grimm, SW; Lin, J; Ribadeneira, MD; Smith, MA; Sunzel, M; Zhou, D | 1 |
| Al-Huniti, N; Lu, Z; Sunzel, M; Xu, H; Zhou, D | 1 |
2 other study(ies) available for midazolam and 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3-carboxamide
| Article | Year |
|---|---|
A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Area Under Curve; Blotting, Western; Caffeine; Cells, Cultured; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Drug Interactions; GABA Modulators; Hepatocytes; Heterocyclic Compounds, 2-Ring; Humans; Male; Midazolam; Middle Aged; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Young Adult | 2012 |
Population pharmacokinetic modelling to assess clinical drug-drug interaction between AZD7325 and midazolam.
Topics: Computer Simulation; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; GABA Modulators; Heterocyclic Compounds, 2-Ring; Humans; Male; Midazolam; Models, Biological; Nonlinear Dynamics; Time Factors | 2014 |